Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hakan Koparal"'
Autor:
Seher Susam, Akın Çinkooğlu, Kenan Can Ceylan, Soner Gürsoy, Berna Eren Kömürcüoğlu, Aydan Mertoğlu, Ali Kadri Çırak, Mine Gayaf, Filiz Güldaval, Fevziye Tuksavul, Gülru Polat, Sena Ataman, Eylem Yıldırım, Hakan Koparal, Nur Yücel
Publikováno v:
The Clinical Respiratory Journal, Vol 16, Iss 11, Pp 740-749 (2022)
Abstract Objective Risk analysis models, which are used in the diagnostic algorithm of incidental pulmonary nodules, are based on patient data from developed countries. Mayo Clinic, Brock University and Herder are among the most known models. We aim
Externí odkaz:
https://doaj.org/article/ff4a6475cd3e440c9d9f15f3ed95b713
Autor:
Aydan, Mertoğlu, Ahmet, Üçvet, Günseli, Balci, Nimet, Aksel, Özgür, Batum, Emel, Cireli, Kenan Can, Ceylan, Hakan, Koparal, Ali Kadri, Çirak, Soner, Gürsoy, Ufuk, Yilmaz, Berna, Kömürcüoğlu
Publikováno v:
Nuclear Medicine Communications. 43:475-482
The aim of this study was to investigate the correlation of preoperative 18F-fluorodeoxyglucose PET/computed tomography maximum standardized uptake value (SUVmax) in operated non-small cell lung cancer (NSCLC) cases with other prognostic parameters a
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular. 37:218-222
espanolObjetivos La quimiorradioterapia concomitante (QRTC) se utiliza de forma amplia para tratar a los pacientes con cancer de pulmon no microcitico (CPNM) en estadio iii. La identificacion precoz de los pacientes con mal pronostico constituye la p
Publikováno v:
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 37:218-222
Objectives Concomitant chemoradiotherapy (CCRT) is widely used in the treatment of patients with stage III non-small lung carcinoma (NSCLC). The early identification of patients with poor prognosis is the premise of personalized treatment for patient
Autor:
Ufuk Yilmaz, Bahri Gumus, Salih Aksit, Tuğçe Çiftçi, Ibrahim Yügünt, Hakan Koparal, Burcu Yalçın
Publikováno v:
Eurasian Journal of Pulmonology, Vol 18, Iss 3, Pp 148-152 (2016)
Objective: The most important factor for accurate treatment of patients with small cell lung carcinoma (SCLC) is accuracy of the initial staging. The aim of this study was to determine how often patients, staged as local or local-advanced disease by
Autor:
Özer Özdemir, Sami Deniz, Hakan Koparal, Özgür Batum, Aydan Mertoğlu, Berna Komurcuoglu, Nimet Aksel, Günseli Balcı, Engin Özbilek, Sinem Ermin, Ufuk Yilmaz
Publikováno v:
Lung cancer.
Autor:
Aydan Mertoğlu, Özer Özdemir, Engin Özbilek, Hakan Koparal, Özgür Batum, Sinem Ermin, Berna Komurcuoglu, Nimet Aksel, Ufuk Yilmaz, Sami Deniz, Günseli Balcı
Publikováno v:
The clinical respiratory journalREFERENCES.
INTRODUCTION There is limited evidence about the prognostic value of FDG-PET/CT metrics in small cell lung cancer (SCLC) patients staged with TNM staging system. OBJECTIVES The aim of this study is to examine the prognostic value of pretreatment FDG-
Autor:
Eylem Yıldırım, Mine Gayaf, Kenan Can Ceylan, Seher Susam, Soner Gürsoy, Berna Komurcuoglu, Ali Kadri Cirak, Filiz Güldaval, Hakan Koparal, Nur Yücel, Aydan Mertoğlu, Fevziye Tuksavul, Gülru Polat, Akın Çinkooğlu
Publikováno v:
The clinical respiratory journalREFERENCES. 14(5)
OBJECTIVES Among the nodule types, the most controversial group are indeterminate solid nodules from 1 to 2 cm in size with the first choice being transthoracic needle biopsy (TTNB) or positron emission tomography (PET-CT) or both methods together. H
Publikováno v:
The Turkish Journal of Thoracic and Cardiovascular Surgery. 24:305-311
Publikováno v:
Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina. 14(2)
Aim Concurrent chemoradiotherapy (CRT) is the standard of care for locally advanced, unresectable non-small cell lung carcinoma (NSCLC). The aim of this study was to assess the prognostic value of maximum standardized uptake values (SUVmax) in patien